Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders.
Hemab Therapeutics Holdings stock last closed at $25.51, up 1.71% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Hemab Therapeutics Holdings stock is currently +10.91% from its 52-week low of $23.00, and -30.22% from its 52-week high of $36.56.
There are currently 46.71M shares of COAG outstanding. The market capitalization of COAG is $1.19B. In the past 24 hours, 370,000 COAG shares were traded.
How to Buy Hemab Therapeutics Holdings Stock
Wondering how to invest in Hemab Therapeutics Holdings stock? Here's how.
Figure out where to buy Hemab Therapeutics Holdings stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Hemab Therapeutics Holdings stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Pick your method of payment and add your information.
Evaluate Hemab Therapeutics Holdings stock: The Hemab Therapeutics Holdings ticker symbol is COAG. Is Hemab Therapeutics Holdings stock a good investment? Should you buy shares of COAG? How do COAG's underlying business fundamentals look? Do top analysts think Hemab Therapeutics Holdings is a good buy? Why has COAG's stock price moved recently? (Hint: Our stock research website can help you evaluate if COAG is a good stock to buy).
Make your COAG purchase: Decide if you will purchase COAG shares at the current market price or use a limit order to purchase COAG stock at a given price.
Get notifications regarding your investment in COAG: Create a watchlist to watch your investment in Hemab Therapeutics Holdings stock.
Step 1: Figure out where to buy Hemab Therapeutics Holdings stock
You need an online brokerage account to access the NASDAQ market and buy COAG shares.
A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in COAG today.
After you have identified the best place to buy Hemab Therapeutics Holdings stock, it's important to analyze their stock before you invest, so you actually wrap your head around the risk and opportunity.
Hemab Therapeutics Holdings Numbers
COAG Price
$25.51
1w %
-5.52%
1y %
N/A
5y %
N/A
P/E
N/A
P/B
-6x
P/S
N/A
PEG
N/A
Revenue
N/A
Earnings
N/A
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$1.19B
Next Earnings
Aug 14, 2026
Next Dividend
N/A
Hemab Therapeutics Holdings Fundamentals
WallStreetZen was built to help average investors perform better fundamental analysis in less time.
No, Hemab Therapeutics Holdings doesn't provide an income stream by paying out dividends.
What do other investors have to say about COAG?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your COAG purchase
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally fine for most investors.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.
Hit the Open Trade button and eToro will execute your order.
If you want additional help buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Hemab Therapeutics Holdings share?
As of Jun 16, 2026, it costs $25.51 to buy one share of Hemab Therapeutics Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.392 shares of COAG.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Is now a good time to buy Hemab Therapeutics Holdings stock?
According to 4 Wall Street analysts who monitor Hemab Therapeutics Holdings, their consensus recommendation is to buy Hemab Therapeutics Holdings stock.
What is the best way to buy Hemab Therapeutics Holdings stock?
One way to place an order for Hemab Therapeutics Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.